DiaMedica Therapeutics Ratios (2018-2019) | DMAC

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019
Profitability
EBT Margin -266.00%
EBIT Margin -297.40%
EBITDA Margin -277.40%
Operating Margin -297.40%
Net Margin -277.40%
FCF Margin -371.80%
Efficiency
Assets Average 16.92M14.15M11.92M
Equity Average 6.05M4.73M10.57M15.47M12.80M10.70M
Invested Capital 6.75M5.36M4.11M17.02M13.91M11.70M9.70M
Asset Utilization Ratio 0.030.04
Leverage & Solvency
Equity Ratio 0.930.900.910.88
Valuation
Enterprise Value -6.71M-5.73M-3.90M-16.82M-13.72M-10.97M-9.74M
Return Ratios
Return on Sales -2.77%-11.47%-16.67%-18.14%
Return on Capital Employed -0.57%-0.74%-1.02%
Return on Invested Capital -0.65%-0.58%-0.77%-1.03%
Return on Assets -0.49%-0.64%-0.85%
Return on Equity -0.54%-0.54%-0.71%-0.95%